Clinical Trials Logo

Filter by:
NCT ID: NCT01005693 Recruiting - Clinical trials for Unspecified Adult Solid Tumor, Protocol Specific

Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment

Start date: October 2009
Phase: N/A
Study type: Interventional

RATIONALE: Questionnaires that measure how well older patients think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer. PURPOSE: This clinical trial is studying testing for fitness to undergo chemotherapy to see how well it works in predicting treatment outcomes in older patients with cancer.

NCT ID: NCT00954811 Recruiting - Pregnancy Clinical Trials

Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

Start date: September 2005
Phase: Phase 4
Study type: Interventional

Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of OHSS.

NCT ID: NCT00948623 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Physical Activity Counseling During Pulmonary Rehabilitation

PAC
Start date: April 2009
Phase: N/A
Study type: Interventional

This randomized controlled trial will assess the effect of adding intensive physical activity counseling to an outpatient pulmonary rehabilitation program. Counseling including real-time feedback on daily activities from an activity monitor will be offered to improve participation in physical activities in daily life during and after an outpatient pulmonary rehabilitation program.

NCT ID: NCT00947622 Recruiting - Fibromyalgia Clinical Trials

Occipital Transcranial Direct Current Stimulation in Fibromyalgia

Start date: July 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to investigate whether transcranial direct current stimulation is effective in the treatment of fibromyalgia related pain. The study provides a placebo arm and the design is a cross-over design.

NCT ID: NCT00903188 Recruiting - Clinical trials for Renal Transplantation

Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation

CISTCERT
Start date: October 2008
Phase: Phase 4
Study type: Interventional

This study intends to determine whether steroid withdrawal or calcineurin inhibitor withdrawal is superior for graft function and graft survival. Secondary endpoints for this study are: incidence of tumors and cardiovascular events. The primary objective: To assess if superior graft function (glomerular filtration rate (GFR) difference of 10 ml/min) will be achieved at 1 year after transplantation in cohorts of de novo kidney transplant patients treated with Myfortic-everolimus plus steroids compared to Myfortic-cyclosporine.

NCT ID: NCT00898118 Recruiting - Leukemia Clinical Trials

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Start date: April 2007
Phase: N/A
Study type: Observational

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples in young patients with cytopenia after undergoing a donor stem cell transplant.

NCT ID: NCT00887146 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Start date: September 2009
Phase: Phase 3
Study type: Interventional

Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving radiation with concomitant and adjuvant temozolomide versus radiation with adjuvant PCV is more effective in treating anaplastic glioma or low grade glioma.

NCT ID: NCT00883402 Recruiting - Carotid Stenosis Clinical Trials

Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients

ACST-2
Start date: January 2008
Phase: N/A
Study type: Interventional

The trial randomise patients with asymptomatic carotid artery narrowing in whom prompt physical intervention is thought to be needed, but there there is still substantial uncertainty shared by patient and doctor about whether surgery or stenting is the more appropriate choice. The study is looking at immediate risks (within one month)and at long term benefits

NCT ID: NCT00859885 Recruiting - Stroke Clinical Trials

International PFO Consortium

Start date: September 8, 2008
Phase: N/A
Study type: Observational

The prevalence of patent foramen ovale (PFO) is about 25% in the general population and approximately 40% in patients who have ischemic stroke of unknown cause (cryptogenic stroke). Given the large number of asymptomatic patients, no primary prevention is currently recommended. On the contrary, secondary prevention is very important. Prospective studies have shown that antithrombotic treatment (ATT) with aspirin or warfarin appears to negate the risk of recurrent stroke associated with a PFO. Patients with spontaneous or large right-to-left shunts (RLS), those with a coinciding atrial septal aneurysm (ASA) or multiple ischemic events prior to the PFO diagnosis may still be at increased risk of stroke recurrence despite ATT. Percutaneous device closure (PDC) is a challenging alternative to ATT. Several studies reported 0% to 3.4% annual recurrence rates of stroke or TIA in patients treated by PDC. To date, there is no data from randomized controlled trials (RCT) comparing the risk of stroke recurrence after PDC with that under ATT only. The results from ongoing RCTs are not to be awaited in the near future, mainly due to low enrolment and event rates. Alternative data-gathering strategies such as multicenter registries are needed to overcome the low recruitment rates. The aim of the present study is to compare the risk of recurrent stroke and TIA in patients with PFO and otherwise unexplained stroke who undergo PDC or receive ATT.

NCT ID: NCT00858520 Recruiting - Lung Cancer Clinical Trials

Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer

Start date: October 2007
Phase: N/A
Study type: Observational

A biobank of Serum, plasma, DNA samples together with clinical information including specific questionnaires, complete pulmonary function and chest CT-scan, is prospectively collected in patients seen at the investigators' clinical service. The objective is to study candidate gene pathways in COPD and or lung cancer and to associate them with the clinical characteristics and phenotypes of COPD/emphysema and lung cancer. In subgroups of well characterised patients, other biological materials are also collected (lung tissue biopsies, peripheral blood mononuclear cells).